SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-U - Current Report Pursuant to Regulation A:
SEC Accession No. 0001213900-19-024366
Filing Date
2019-11-21
Accepted
2019-11-21 17:17:44
Documents
3
Period of Report
2019-11-15
Items
Item 9.1: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT PURSUANT TO REGULATION A f1u111519_emeraldhealth.htm 1-U 15875
2 BOARD OBSERVER AGREEMENT DATED NOVEMBER 15, 2019 BETWEEN THE COMPANY AND EMERALD f1u111519ex6-1_emerald.htm EX1U-6 MAT CTRCT 15792
3 AMENDMENT AGREEMENT NO. 2 DATED NOVEMBER 15, 2019 BETWEEN THE COMPANY AND EMERAL f1u111519ex6-2_emerald.htm EX1U-6 MAT CTRCT 16388
  Complete submission text file 0001213900-19-024366.txt   49103
Mailing Address 5910 PACIFIC CENTER BLVD SUITE 300, SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD SUITE 300, SAN DIEGO CA 92121 (858) 352-0622
Emerald Health Pharmaceuticals Inc. (Filer) CIK: 0001700800 (see all company filings)

IRS No.: 820669961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-U | Act: 33 | File No.: 24R-00152 | Film No.: 191238082
SIC: 2834 Pharmaceutical Preparations